[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Hepatitis Market Research Reports & Industry Analysis

The notion “hepatitis” means inflammation of the liver or its cells, often caused by some virus and accompanied in its initial phase to by symptoms similar to flu: fever, loss of appetite, muscle/joint aches, etc. According to the virus type hepatitis is divided into several types: hepatitis A, В C, D and E. Hepatitis can disappear on its own, but in some cases it can lead to serious liver dysfunctions and severe complications such as fibrosis, liver failure or cancer, cryoglobulinemia, an a lot more.

The world hepatitis drugs market has experienced stable growth over the recent years, driven by the constant increase of demand from developed countries, introduction of new products and technological advancement in the medical industry. It is set to continue growing at a CARG of above 12% through 2015. Gilead Sciences, Merck & Co., GlaxoSmithKline, Bristol-Myers Squibb and Hoffmann-La Roche are amid the key hepatitis market players.

The collection of the research reports found in this catalogue provides an extensive insight into the hepatitis market at different geographical scales. Relevant information on the market size, share, segmentation as well as major factors influencing the market is presented in the researches. The reports offer detailed assessment of the competitive landscape and profile top companies. In addition, discussions of future market prospects for the are at hand in the research reports.

Publications found: 175
Sort by:
Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019 US$ 4,000.00

Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2018 SUMMARY GlobalData's Medical Devices sector report, “Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2018' provides an overview of Hepatitis Test Kits ... important and diverse types of Hepatitis Test Kits under development Develop market- ...

December 2019 279 pages
Hepatitis Viruses Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019 US$ 4,000.00

... Devices sector report, “Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Medical Devices Pipeline Assessment, 2017' provides an overview of Hepatitis Viruses Rapid Tests ... Hepatitis Viruses Rapid Tests & POC (Point Of Care) and list all their pipeline projects The coverage of pipeline products based ...

November 2019 130 pages
Hepatitis B: Competitive Landscape to 2027 US$ 3,495.00

... approvals to improve the treatment options of Hepatitis B over the next decade (2017-2027). SCOPE GlobalData’s Hepatitis B: Competitive Landscape to 2027 combines data from the ...

May 2019 49 pages
France Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review US$ 3,900.00

... report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications ...

May 2019 241 pages
Germany Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review US$ 3,900.00

... report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications ...

May 2019 241 pages
Italy Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review US$ 3,900.00

... report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of ...

May 2019 241 pages
Japan Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review US$ 3,900.00

... report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of ...

May 2019 241 pages
Spain Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review US$ 3,900.00

... report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of ...

May 2019 241 pages
UK Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review US$ 3,900.00

... ,HBVNAT,HBsAg,HCV,Anti-HBc,Anti-HBs,Anti-HAV,Hepatitis Delta,HBc Ag,HBe Ag, andALT/SGPT In addition to test volume and ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...

May 2019 241 pages
US Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review US$ 3,900.00

... ,HBVNAT,HBsAg,HCV,Anti-HBc,Anti-HBs,Anti-HAV,Hepatitis Delta,HBc Ag,HBe Ag, andALT/SGPT In addition to test volume and ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...

May 2019 241 pages
Hepatitis B Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model US$ 7,500.00

Hepatitis B Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model SUMMARY Hepatitis B Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualiz...

May 2019
Hepatitis C Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model US$ 7,500.00

Hepatitis C Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model SUMMARY Hepatitis C Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualiz...

May 2019
Global Hepatitis A Vaccine Industry Market Research 2019 US$ 2,600.00

... overall research conclusions are offered. Key players in global Hepatitis A Vaccine market include: GSK Merck Sanofi Sinovac Zhejiang Pukang ... growth? 10. What are the Hepatitis A Vaccine market opportunities and threats faced by the vendors in the global Hepatitis A Vaccine market? Objective of Studies: 1. ...

February 2019 163 pages
Global Hepatitis Diagnostics Test Industry Market Research 2019 US$ 2,600.00

... are the Hepatitis Diagnostics Test market challenges to market growth? 10. What are the Hepatitis Diagnostics Test market opportunities and threats faced by the vendors in the global Hepatitis Diagnostics Test market ...

February 2019 156 pages
Global Hepatitis Test Diagnosis Industry Market Research 2019 US$ 2,600.00

... are the Hepatitis Test Diagnosis market challenges to market growth? 10. What are the Hepatitis Test Diagnosis market opportunities and threats faced by the vendors in the global Hepatitis Test Diagnosis market ...

February 2019 147 pages
Global Hepatitis Test Solution Industry Market Research 2019 US$ 2,600.00

... are the Hepatitis Test Solution market challenges to market growth? 10. What are the Hepatitis Test Solution market opportunities and threats faced by the vendors in the global Hepatitis Test Solution market ...

February 2019 153 pages
Global Hepatitis C Virus And Therapeutics Industry Market Research 2019 US$ 2,600.00

... overall research conclusions are offered. Key players in global Hepatitis C Virus And Therapeutics market include: Gilead Johnson & Johnson Bristol ... Therapeutics market opportunities and threats faced by the vendors in the global Hepatitis C Virus And Therapeutics market? Objective of Studies: 1. To provide ...

February 2019 159 pages
Global Hepatitis C Treatment Industry Market Research 2019 US$ 2,600.00

... overall research conclusions are offered. Key players in global Hepatitis C Treatment market include: AbbieVie Inc. Bristol-Myers Squibb ... growth? 10. What are the Hepatitis C Treatment market opportunities and threats faced by the vendors in the global Hepatitis C Treatment market? Objective of Studies: ...

February 2019 160 pages
Global Hepatitis E Diagnostic Tests Industry Market Research 2019 US$ 2,600.00

... are the Hepatitis E Diagnostic Tests market challenges to market growth? 10. What are the Hepatitis E Diagnostic Tests market opportunities and threats faced by the vendors in the global Hepatitis E Diagnostic Tests market ...

February 2019 164 pages
Global Hepatitis Marker Testing Industry Market Research 2019 US$ 2,600.00

... are the Hepatitis Marker Testing market challenges to market growth? 10. What are the Hepatitis Marker Testing market opportunities and threats faced by the vendors in the global Hepatitis Marker Testing market ...

February 2019 152 pages
Global Hepatitis Therapeutics Industry Market Research 2019 US$ 2,600.00

... of the Hepatitis Therapeutics market? 9. What are the Hepatitis Therapeutics market challenges to market growth? 10. What are the Hepatitis Therapeutics market opportunities and threats faced by the vendors in the global Hepatitis Therapeutics market? Objective of Studies ...

February 2019 153 pages
Global Autoimmune Hepatitis Diagnosis and Treatment Market Forecast, 2018-2023 US$ 3,600.00

... and following segments: 1. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Diagnosis 2. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Treatment 3. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Type 4. Global Autoimmune Hepatitis Diagnosis and Treatment Market ...

January 2019
Alcoholic Hepatitis Global Clinical Trials Review, H2, 2018 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

October 2018 81 pages
2018-2023 Global and Regional Hepatitis E Diagnostic Tests Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report US$ 3,500.00

... is 2017, and the market size is projected from 2018 to 2023. The growing incidence of hepatitis E, a liver disease caused by infection due to ... of morbidity and mortality worldwide. There is increasing prevalence of hepatitis E in resource-limited region, such as various countries of Asia Pacific. The people ...

August 2018 182 pages
Global Hepatitis vaccine Industry Market Research 2018 US$ 2,600.00

... of the Hepatitis vaccine market? 9. What are the Hepatitis vaccine market challenges to market growth? 10. What are the Hepatitis vaccine market opportunities and threats faced by the vendors in the global Hepatitis vaccine market? Objective of Studies ...

July 2018 158 pages
Hepatitis C: Competitive Landscape to 2026 US$ 3,495.00

Hepatitis C: Competitive Landscape to 2026 SUMMARY Hepatitis C is a liver infection caused by the hepatitis C virus (HCV), a small enveloped RNA virus. If ... impact the global hepatitis C market in the future. Formulate effective sales and marketing strategies by understanding the competitive landscape and by ...

June 2018 49 pages
Hepatitis Drug Development Pipeline Review, 2018 US$ 3,995.00

Hepatitis Drug Development Pipeline Review, 2018 SUMMARY This report provides an overview of the pipeline landscape for hepatitis infections. It provides comprehensive information on the therapeutics under development and key players ...

June 2018 133 pages
Hepatitis C: Drug Development Pipeline Study, H2 2018 US$ 1,500.00

... cirrhosis or liver cancer. Hepatitis C pipeline comprises of 85 active drugs under active development as of June 2018. Of these, 16 drugs are in Phase 1 and 19 drugs in phase 2. Only 4 drugs progressed to Phase 3. Further ...

June 2018 150 pages
Hepatitis E - Pipeline Review, H1 2018 US$ 2,000.00

... releases. The Hepatitis E (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis E and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

June 2018 28 pages
Global Hepatitis B Virus Core Antibody Diagnostic Kits Industry Market Research 2018 US$ 2,600.00

... are the Hepatitis B Virus Core Antibody Diagnostic Kits market opportunities and threats faced by the vendors in the global Hepatitis B Virus Core Antibody Diagnostic ... of the various segments and sub-segments of the global Hepatitis B Virus Core Antibody Diagnostic Kits market. 2. To provide insights about ...

June 2018 147 pages
Hepatitis B - Pipeline Review, H1 2018 US$ 2,000.00

... releases. The Hepatitis B (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis B and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

May 2018 365 pages
Hepatitis Diagnostic Test Market Size, Share & Trends Analysis Report, By Diagnostic Tests (Liver Function, Immunoassays & Nucleic Acid Assays, Imaging, Liver Biopsy), And Segment Forecasts, 2018 - 2025 US$ 5,950.00

... hepatitis diagnostics market is expected to reach USD 6.9 billion by 2025, according to a new report by Grand View Research, Inc. In the past decade, the burden of hepatitis ... rendering a positive impact on the market growth owing to rising demand for diagnostic tests. Furthermore, the adoption of molecular ...

May 2018 90 pages
Hepatitis D - Pipeline Review, H1 2018 US$ 2,000.00

... releases. The Hepatitis D (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis D and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2018 60 pages
Hepatitis A - Pipeline Review, H1 2018 US$ 2,000.00

... releases. The Hepatitis A (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis A and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2018 26 pages
Hepatitis C - Pipeline Review, H1 2018 US$ 2,000.00

... releases. The Hepatitis C (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis C and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

March 2018 431 pages
Alcoholic Hepatitis - Pipeline Review, H1 2018 US$ 2,000.00

... releases. The Alcoholic Hepatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Alcoholic Hepatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

March 2018 69 pages
The 2019-2024 World Outlook for Hepatitis C Virus (HCV) Therapeutics US$ 995.00

This study covers the world outlook for hepatitis c virus (HCV) therapeutics across more than 190 countries. For each year reported ... demand, or the P.I.E., for hepatitis c virus (HCV) therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...

January 2018 269 pages
The 2019-2024 World Outlook for Hepatitis Drugs US$ 995.00

This study covers the world outlook for hepatitis drugs across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for hepatitis drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country ...

January 2018 268 pages
The 2019-2024 World Outlook for Hepatitis B Therapeutics US$ 995.00

This study covers the world outlook for hepatitis B therapeutics across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for hepatitis B therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

January 2018 268 pages
The 2019-2024 World Outlook for Hepatitis C Therapies US$ 995.00

This study covers the world outlook for hepatitis C therapies across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for hepatitis C therapies. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

January 2018 268 pages
The 2019-2024 World Outlook for Hepatitis C Treatments US$ 995.00

This study covers the world outlook for hepatitis C treatments across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for hepatitis C treatments. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

January 2018 268 pages
Hepatitis Treatment Market, 2012 to 2023 US$ 4,400.00

... , Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Market Outline: Hepatitis Treatment Market Hepatitis is the disease characterized by the inflammation of the ...

January 2018 202 pages
Global Hepatitis B Virus Testing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 US$ 4,400.00

... high cost of testing are expected to hamper the hepatitis B virus testing market over the forecast period. The global hepatitis B testing market is classified on the basis of test type, technique ...

November 2017 210 pages
Global Hepatitis C Virus Testing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 US$ 4,400.00

... hepatitis C virus testing market. Globally, hepatitis C virus testing market is segmented based on technique, test type, end-user. Based on technique, hepatitis C virus testing market is segmented as: Polymerase Chain Reaction Tests Immunoassays Others Based on test, hepatitis C virus testing ...

November 2017 221 pages
Hepatitis B Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

September 2017 867 pages
Hepatitis C Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

September 2017 1564 pages
Hepatitis D Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

September 2017 58 pages
Hepatitis E Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

September 2017 34 pages
Hepatitis A Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

September 2017 84 pages
Hepatitis C Therapeutics in Asia-Pacific Markets to 2023 - Presence of Outstanding Direct-Acting Antivirals and Late-Stage Pipeline to Transform the Clinical and Commercial Landscape US$ 4,995.00

... from hepatitis C, mostly due to cirrhosis and hepatocellular carcinoma. The APAC region has diverse HCV epidemiology, with prevalence ranging from 0.1% to 4.7%, and a unique genotype (GT) distribution ...

July 2017 138 pages

Filters

Search

Publishers

1
1
1
11
1
6
5
3
15
2
1
2
1
97
1
2
1
8
4
3
2
6
1

Regions

1
12
11
11
11
10
8
14
11
86

Price

Date

Pages

Offers